Nuzenio

Tradingview Mirum Pharmaceuticals

Tradingview Mirum Pharmaceuticals entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Mirum Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $138.21, Implies 31% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:21 GMTCitizens Says FDA’s 'Unexpected' Phase 3 Request Clouds Mirum’s Near-Term Outlook – MIRM Stock Crashes 15% - TradingViewTradingView · Thu, 06 Aug 2026 13:46:32 GMTMirum Pharmaceuticals Q2 sales rise, lifts outlook - TradingViewTradingView · Wed, 05 Aug 2026 20:12:03 GMTMIRM5806400 Bond Coupon Profile — Rate & Payments - TradingViewTradingView · Sat, 01 Aug 2026 02:15:16 GMT

Timeline

Thu, 06 Aug 2026 17:20:21 GMTMirum Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $138.21, Implies 31% Upside - TradingView
Thu, 06 Aug 2026 13:46:32 GMTCitizens Says FDA’s 'Unexpected' Phase 3 Request Clouds Mirum’s Near-Term Outlook – MIRM Stock Crashes 15% - TradingView
Wed, 05 Aug 2026 20:12:03 GMTMirum Pharmaceuticals Q2 sales rise, lifts outlook - TradingView
Sat, 01 Aug 2026 02:15:16 GMTMIRM5806400 Bond Coupon Profile — Rate & Payments - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Mirum Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.